Second Metabolite Composition, Antioxidative, Tyrosinase Inhibitory, Antibacterial and Anticancer Activity of Balanophora laxiflora Extract

Tran Thi Hang, Tran Thi Quyen, Nguyen Quang Huy, Le Thi Phuong Hoa

Article Sidebar

PDF
Published Jun 15, 2016

Article Details

How to Cite
HANG, Tran Thi et al. Second Metabolite Composition, Antioxidative, Tyrosinase Inhibitory, Antibacterial and Anticancer Activity of Balanophora laxiflora Extract. VNU Journal of Science: Natural Sciences and Technology, [S.l.], v. 32, n. 2, june 2016. ISSN 2588-1140. Available at: <https://js.vnu.edu.vn/NST/article/view/1656>. Date accessed: 05 may 2024.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 32 No 2
Section
Review Articles

Main Article Content

Abstract

Abstract: Balanophora laxiflora extract contains various compounds including terpenoids, phenolics, and flavonoids. Ethyl acetate fraction of B. laxiflora has high content of phenolic compounds  (608.21 mg GAE/g), highly correlated with its antioxidant activity including 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging capacity (IC50 value of 22.81 µg/mL) and reducing power (2.33), which is comparable to that of ascorbic acid and quecertin. This fraction shows strong tyrosinase inhibitory activity with IC50 value of 7.9 µg/mL and mild inhibitory activity against Gram-positive and Gram-negative strains at the concentration of 20 mg/mL, stronger than those of other fractions. Ethyl acetate fraction also exhibited cytotoxicity against human lung carcinoma (LU-1) cell line. n-Hexane fraction shows stronger activity on epidermal carcinoma (KB) cell lines (IC50 = 3.45 µg/mL). Median lethal dose (LD50) of B. laxiflora methanolic crude extract on experimental mice is 10.64 g/kg body mass. The results suggest new pharmacological use of B. laxiflora especially in depigmentation, cancer treatment and further characterization of bioactive constituents and biological activities of ethyl acetate and n-hexane fraction.

Keywords: Balanophora laxiflora, antioxidative activity, tyrosinase inhibition, antibacterial activity, anticancer activity

References

[1] Do Tat Loi, Vietnamese medicinal plants and remedies, Medical Publishing House, Hanoi, (2004) 914 (In Vietnamese).
[2] X.H. Wang, Z. Liu, Z. Liu, W. Qiao, R. Cheng, B. Liu and G. She, Phytochemicals and biological studies of plants from the genus Balanophora, Chemistry Central Journal 6 (2012), 79.
[3] G.M. She, Y.J. Zhang, C.R. Yang, Phenolic constituents from Balanophora laxiflora with DPPH radical-scavenging activity, Chemistry and Biodiversity 6 (2009) 875.
[4] S.T. Ho, Y.T. Tung, K.C. Cheng, J.H. Wu, Screening, determination and quantification of major antioxidants from Balanophora laxiflora flowers, Food Chemistry 122 (2010) 584.
[5] W.F. Chiou, C.C. Shen and L.C. Lin, Anti-Inflammatory Principles from Balanophora laxiflora, Journal of Food and Drug Alalysis 4 (2011) 502.
[6] S.T. Ho, Y.T. Tung, C.H. Huang, C.L. Kuo, C.C. Lin, S.C. Yang, J.H. Wu, The hypouricemic effect of Balanophora laxiflora extracts and derived phytochemical in hyperuricemic mice, Evidence- Based Complementary and Alternative Medicine (2012) 1.
[7] Nguyen Thanh Huong, Nguyen Tran Thi Giang Huong, Phan Anh Tuan, Truong Van Huong, Study on the androgenic properties of Balanophora laxiflora extracts on male rats, Journal of Medicinal Research 96 (4) (2015) 31.
[8] A.L. Waterhouse, Determination of total phenolics, In Current Protocols in Food Analytical Chemistry, (2002) I1.1.1
[9] K. Sapkota, S.E. Park, J.E. Kim, S. Kim, H.S. Choi, H..Schun, and S.P. Voravuthikunchai, Antoxidant and antimelanogenic properties of chestnut flower extract, Biotech and Biochem 74(8) (2010) 1527.
[10] M.S. Blois, Antioxidant determination by the use of a stable free radical, Nature 181 (1958) 1199.
[11] A. Yagi, T. Kanbara and N. Morinobu, Inhibition of mushroom - tyrosinase by aloe extract, Planta Med 53 (1987) 515.
[12] P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken, Manual of Clinical Microbiology, 6th Edition, ASM Press, Washington, DC, (1995) 15.
[13] D.A. Scudiero, R.H. Shoemaker, D.P. Kenneth, A. Monks, S. Tierney, T.H. Nofziger, M.J. Currens, D. Seniff and M.R. Boyd, Evaluation of a soluable tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines, Cancer Research, 48 (1988) 4827.
[14] S. Trakulsomboon, T. Kummalue, W. Jiratchariyakul, Antibacterial Activities of Four Thai Medicinal Plants, J Med Assoc Thai 89 (9) (2006) 1466.
[15] J. Pokorný, Natural antioxidants for food use, Trends in Food Science & Technology 2 (1991) 223.
[16] T. Ogi, M. Higa, and S. Maruyama, Melanin Synthesis Inhibitors from Balanophora fungosa, J. Agric. Food Chem 59 (4) (2011) 1109.
[17] T. Hosoya, A. Nakata, K. Zaima, J. Latip, L.B. Din, N. Muslim, and H. Morita, Papuabalanols A and B, New Tannins from Balanophora papuana, Chem. Pharm. Bull 58(5) (2010) 738.
[18] Z.H. Jiang, X.Y. Wen, T. Tanaka, S.Y. Wu, Z.Q. Liu, H. Iwata, Y. Hirose, S.G. Wu, I. Kouno, Cytotoxic hydrolyzable tannins from Balanophora japonica, J Nat Prod 71 (2008) 719.